

A new COVID-19 variant, identified as PJ.2.1, has reportedly been detected in several countries, raising fresh concerns about the spread of the virus. According to the information provided, the variant was first identified in Canada on May 2, 2026. It has since been reported in countries including the United States, France, Singapore and Australia. Researchers have reportedly identified genetic changes in the virus's spike protein, which plays a key role in its ability to enter human cells.
The reported symptoms of PJ.2.1 include fever, cough, sore throat, runny nose, headache, body aches and severe fatigue. However, there is currently no confirmed evidence that this variant is more dangerous than earlier strains. Older adults and people with underlying conditions such as diabetes and heart disease are advised to remain cautious. As of the information provided, there are no confirmed reports of PJ.2.1 cases in India. Further information from health authorities and ongoing research will be important in understanding the variant's spread and potential impact.























Comments (0)
No comments yet
Be the first to comment!